These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28442662)

  • 1. Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases.
    Tominaga K; Yamagiwa S; Setsu T; Kimura N; Honda H; Kamimura H; Honda Y; Takamura M; Yokoyama J; Suzuki K; Wakai T; Terai S
    Biomed Res; 2017; 38(2):111-121. PubMed ID: 28442662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
    Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis.
    Hayashi E; Chiba A; Tada K; Haga K; Kitagaichi M; Nakajima S; Kusaoi M; Sekiya F; Ogasawara M; Yamaji K; Tamura N; Takasaki Y; Miyake S
    J Rheumatol; 2016 Sep; 43(9):1695-703. PubMed ID: 27370879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
    Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
    J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.
    Braudeau C; Amouriaux K; Néel A; Herbreteau G; Salabert N; Rimbert M; Martin JC; Hémont C; Hamidou M; Josien R
    J Autoimmun; 2016 Jun; 70():73-9. PubMed ID: 27102145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis.
    Setsu T; Yamagiwa S; Tominaga K; Kimura N; Honda H; Kamimura H; Tsuchiya A; Takamura M; Terai S
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1286-1294. PubMed ID: 29266628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
    Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
    Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.
    Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA
    Front Immunol; 2018; 9():1076. PubMed ID: 29868028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal-Associated Invariant T Cell Levels Are Reduced in the Peripheral Blood and Lungs of Children With Active Pulmonary Tuberculosis.
    Malka-Ruimy C; Ben Youssef G; Lambert M; Tourret M; Ghazarian L; Faye A; Caillat-Zucman S; Houdouin V
    Front Immunol; 2019; 10():206. PubMed ID: 30853958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma.
    Ishimori A; Harada N; Chiba A; Harada S; Matsuno K; Makino F; Ito J; Ohta S; Ono J; Atsuta R; Izuhara K; Takahashi K; Miyake S
    Allergol Int; 2017 Apr; 66(2):302-309. PubMed ID: 27575652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and Functional Alteration of Mucosal-Associated Invariant T Cells in Adult Patients With Community-Acquired Pneumonia.
    Ouyang L; Wu M; Shen Z; Cheng X; Wang W; Jiang L; Zhao J; Gong Y; Liang Z; Weng X; Yu M; Wu X
    Front Immunol; 2021; 12():788406. PubMed ID: 34992604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.
    Deschler S; Kager J; Erber J; Fricke L; Koyumdzhieva P; Georgieva A; Lahmer T; Wiessner JR; Voit F; Schneider J; Horstmann J; Iakoubov R; Treiber M; Winter C; Ruland J; Busch DH; Knolle PA; Protzer U; Spinner CD; Schmid RM; Quante M; Böttcher K
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
    Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
    Front Immunol; 2019; 10():1580. PubMed ID: 31354725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases.
    Wei L; Chen Z; Lv Q
    Amino Acids; 2023 Dec; 55(12):1819-1827. PubMed ID: 37819474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
    Zumwalde NA; Haag JD; Gould MN; Gumperz JE
    Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive Phenotypic Analysis, Transcription Factor Profiling, and Effector Cytokine Production of Human MAIT Cells by Flow Cytometry.
    Dias J; Sandberg JK; Leeansyah E
    Methods Mol Biol; 2017; 1514():241-256. PubMed ID: 27787804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating IL-17-producing mucosal-associated invariant T cells (MAIT) are associated with symptoms in children with asthma.
    Lezmi G; Abou Taam R; Dietrich C; Chatenoud L; de Blic J; Leite-de-Moraes M
    Clin Immunol; 2018 Mar; 188():7-11. PubMed ID: 29196148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.